Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 221

1.

The Molecular Basis for Inhibition of Stemlike Cancer Cells by Salinomycin.

Huang X, Borgström B, Stegmayr J, Abassi Y, Kruszyk M, Leffler H, Persson L, Albinsson S, Massoumi R, Scheblykin IG, Hegardt C, Oredsson S, Strand D.

ACS Cent Sci. 2018 Jun 27;4(6):760-767. doi: 10.1021/acscentsci.8b00257. Epub 2018 Jun 14.

2.

Galectins at a glance.

Johannes L, Jacob R, Leffler H.

J Cell Sci. 2018 May 1;131(9). pii: jcs208884. doi: 10.1242/jcs.208884. Review.

PMID:
29717004
3.

Designing interactions by control of protein-ligand complex conformation: tuning arginine-arene interaction geometry for enhanced electrostatic protein-ligand interactions.

Noresson AL, Aurelius O, Öberg CT, Engström O, Sundin AP, Håkansson M, Stenström O, Akke M, Logan DT, Leffler H, Nilsson UJ.

Chem Sci. 2017 Dec 4;9(4):1014-1021. doi: 10.1039/c7sc04749e. eCollection 2018 Jan 28.

4.

Different angioregulatory activity of monovalent galectin-9 isoforms.

Aanhane E, Schulkens IA, Heusschen R, Castricum K, Leffler H, Griffioen AW, Thijssen VL.

Angiogenesis. 2018 Aug;21(3):545-555. doi: 10.1007/s10456-018-9607-8. Epub 2018 Mar 2.

PMID:
29500586
5.

Galectin-3 type-C self-association on neutrophil surfaces; The carbohydrate recognition domain regulates cell function.

Sundqvist M, Welin A, Elmwall J, Osla V, Nilsson UJ, Leffler H, Bylund J, Karlsson A.

J Leukoc Biol. 2018 Feb;103(2):341-353. doi: 10.1002/JLB.3A0317-110R. Epub 2018 Jan 10.

PMID:
29345346
6.

Systematic Tuning of Fluoro-galectin-3 Interactions Provides Thiodigalactoside Derivatives with Single-Digit nM Affinity and High Selectivity.

Peterson K, Kumar R, Stenström O, Verma P, Verma PR, Håkansson M, Kahl-Knutsson B, Zetterberg F, Leffler H, Akke M, Logan DT, Nilsson UJ.

J Med Chem. 2018 Feb 8;61(3):1164-1175. doi: 10.1021/acs.jmedchem.7b01626. Epub 2018 Jan 11.

7.

Monosaccharide Derivatives with Low-Nanomolar Lectin Affinity and High Selectivity Based on Combined Fluorine-Amide, Phenyl-Arginine, Sulfur-π, and Halogen Bond Interactions.

Zetterberg FR, Peterson K, Johnsson RE, Brimert T, Håkansson M, Logan DT, Leffler H, Nilsson UJ.

ChemMedChem. 2018 Jan 22;13(2):133-137. doi: 10.1002/cmdc.201700744. Epub 2018 Jan 15.

PMID:
29194992
8.

Spindle pole cohesion requires glycosylation-mediated localization of NuMA.

Magescas J, Sengmanivong L, Viau A, Mayeux A, Dang T, Burtin M, Nilsson UJ, Leffler H, Poirier F, Terzi F, Delacour D.

Sci Rep. 2017 May 3;7(1):1474. doi: 10.1038/s41598-017-01614-6.

9.

Galectin-3 Inhibition by a Small-Molecule Inhibitor Reduces Both Pathological Corneal Neovascularization and Fibrosis.

Chen WS, Cao Z, Leffler H, Nilsson UJ, Panjwani N.

Invest Ophthalmol Vis Sci. 2017 Jan 1;58(1):9-20. doi: 10.1167/iovs.16-20009.

10.

Perdeuteration, crystallization, data collection and comparison of five neutron diffraction data sets of complexes of human galectin-3C.

Manzoni F, Saraboji K, Sprenger J, Kumar R, Noresson AL, Nilsson UJ, Leffler H, Fisher SZ, Schrader TE, Ostermann A, Coates L, Blakeley MP, Oksanen E, Logan DT.

Acta Crystallogr D Struct Biol. 2016 Nov 1;72(Pt 11):1194-1202. Epub 2016 Oct 28.

11.

A Selective Galactose-Coumarin-Derived Galectin-3 Inhibitor Demonstrates Involvement of Galectin-3-glycan Interactions in a Pulmonary Fibrosis Model.

Rajput VK, MacKinnon A, Mandal S, Collins P, Blanchard H, Leffler H, Sethi T, Schambye H, Mukhopadhyay B, Nilsson UJ.

J Med Chem. 2016 Sep 8;59(17):8141-7. doi: 10.1021/acs.jmedchem.6b00957. Epub 2016 Aug 23.

PMID:
27500311
12.

Erratum: Pathological lymphangiogenesis is modulated by galectin-8-dependent crosstalk between podoplanin and integrin-associated VEGFR-3.

Chen WS, Cao Z, Sugaya S, Lopez MJ, Sendra VG, Laver N, Leffler H, Nilsson UJ, Fu J, Song J, Xia L, Hamrah P, Panjwani N.

Nat Commun. 2016 Jul 19;7:12063. doi: 10.1038/ncomms12063. No abstract available.

13.

Galectin-3-Binding Glycomimetics that Strongly Reduce Bleomycin-Induced Lung Fibrosis and Modulate Intracellular Glycan Recognition.

Delaine T, Collins P, MacKinnon A, Sharma G, Stegmayr J, Rajput VK, Mandal S, Cumpstey I, Larumbe A, Salameh BA, Kahl-Knutsson B, van Hattum H, van Scherpenzeel M, Pieters RJ, Sethi T, Schambye H, Oredsson S, Leffler H, Blanchard H, Nilsson UJ.

Chembiochem. 2016 Sep 15;17(18):1759-70. doi: 10.1002/cbic.201600285. Epub 2016 Aug 12.

PMID:
27356186
14.

Low or No Inhibitory Potency of the Canonical Galectin Carbohydrate-binding Site by Pectins and Galactomannans.

Stegmayr J, Lepur A, Kahl-Knutson B, Aguilar-Moncayo M, Klyosov AA, Field RA, Oredsson S, Nilsson UJ, Leffler H.

J Biol Chem. 2016 Jun 17;291(25):13318-34. doi: 10.1074/jbc.M116.721464. Epub 2016 Apr 26.

15.

Pathological lymphangiogenesis is modulated by galectin-8-dependent crosstalk between podoplanin and integrin-associated VEGFR-3.

Chen WS, Cao Z, Sugaya S, Lopez MJ, Sendra VG, Laver N, Leffler H, Nilsson UJ, Fu J, Song J, Xia L, Hamrah P, Panjwani N.

Nat Commun. 2016 Apr 12;7:11302. doi: 10.1038/ncomms11302.

16.

Intra- and intermolecular interactions of human galectin-3: assessment by full-assignment-based NMR.

Ippel H, Miller MC, Vértesy S, Zheng Y, Cañada FJ, Suylen D, Umemoto K, Romanò C, Hackeng T, Tai G, Leffler H, Kopitz J, André S, Kübler D, Jiménez-Barbero J, Oscarson S, Gabius HJ, Mayo KH.

Glycobiology. 2016 Aug;26(8):888-903. doi: 10.1093/glycob/cww021. Epub 2016 Feb 23.

17.

Immunohistochemical Studies on Galectin Expression in Colectomised Patients with Ulcerative Colitis.

Block M, Mölne J, Leffler H, Börjesson L, Breimer ME.

Biomed Res Int. 2016;2016:5989128. doi: 10.1155/2016/5989128. Epub 2016 Jan 18.

18.
19.
20.

Microglia-Secreted Galectin-3 Acts as a Toll-like Receptor 4 Ligand and Contributes to Microglial Activation.

Burguillos MA, Svensson M, Schulte T, Boza-Serrano A, Garcia-Quintanilla A, Kavanagh E, Santiago M, Viceconte N, Oliva-Martin MJ, Osman AM, Salomonsson E, Amar L, Persson A, Blomgren K, Achour A, Englund E, Leffler H, Venero JL, Joseph B, Deierborg T.

Cell Rep. 2015 Mar 4. pii: S2211-1247(15)00140-0. doi: 10.1016/j.celrep.2015.02.012. [Epub ahead of print]

21.

The role of Galectin-3 in α-synuclein-induced microglial activation.

Boza-Serrano A, Reyes JF, Rey NL, Leffler H, Bousset L, Nilsson U, Brundin P, Venero JL, Burguillos MA, Deierborg T.

Acta Neuropathol Commun. 2014 Nov 12;2:156. doi: 10.1186/s40478-014-0156-0.

22.

Gal-3 regulates the capacity of dendritic cells to promote NKT-cell-induced liver injury.

Volarevic V, Markovic BS, Bojic S, Stojanovic M, Nilsson U, Leffler H, Besra GS, Arsenijevic N, Paunovic V, Trajkovic V, Lukic ML.

Eur J Immunol. 2015 Feb;45(2):531-43. doi: 10.1002/eji.201444849. Epub 2014 Nov 27.

23.

Synthesis and evaluation of iminocoumaryl and coumaryl derivatized glycosides as galectin antagonists.

Rajput VK, Leffler H, Nilsson UJ, Mukhopadhyay B.

Bioorg Med Chem Lett. 2014 Aug 1;24(15):3516-20. doi: 10.1016/j.bmcl.2014.05.063. Epub 2014 Jun 9.

PMID:
24973029
24.

Ligand binding and complex formation of galectin-3 is modulated by pH variations.

von Mach T, Carlsson MC, Straube T, Nilsson U, Leffler H, Jacob R.

Biochem J. 2014 Jan 1;457(1):107-15. doi: 10.1042/BJ20130933.

PMID:
24147723
25.

Galectin-3 guides intracellular trafficking of some human serotransferrin glycoforms.

Carlsson MC, Bengtson P, Cucak H, Leffler H.

J Biol Chem. 2013 Sep 27;288(39):28398-408. doi: 10.1074/jbc.M113.487793. Epub 2013 Aug 7.

26.

Investigation into the feasibility of thioditaloside as a novel scaffold for galectin-3-specific inhibitors.

Bum-Erdene K, Gagarinov IA, Collins PM, Winger M, Pearson AG, Wilson JC, Leffler H, Nilsson UJ, Grice ID, Blanchard H.

Chembiochem. 2013 Jul 22;14(11):1331-42. doi: 10.1002/cbic.201300245.

PMID:
23864426
27.

Tuning the preference of thiodigalactoside- and lactosamine-based ligands to galectin-3 over galectin-1.

van Hattum H, Branderhorst HM, Moret EE, Nilsson UJ, Leffler H, Pieters RJ.

J Med Chem. 2013 Feb 14;56(3):1350-4. doi: 10.1021/jm301677r. Epub 2013 Jan 23.

PMID:
23281927
28.

Galectin-3 deficiency protects pancreatic islet cells from cytokine-triggered apoptosis in vitro.

Saksida T, Nikolic I, Vujicic M, Nilsson UJ, Leffler H, Lukic ML, Stojanovic I, Stosic-Grujicic S.

J Cell Physiol. 2013 Jul;228(7):1568-76. doi: 10.1002/jcp.24318.

PMID:
23280610
29.

Glycosphingolipid composition of epithelial cells isolated along the villus axis of small intestine of a single human individual.

Breimer ME, Hansson GC, Karlsson KA, Larson G, Leffler H.

Glycobiology. 2012 Dec;22(12):1721-30. doi: 10.1093/glycob/cws115. Epub 2012 Jul 24.

PMID:
22833314
30.

Ligand induced galectin-3 protein self-association.

Lepur A, Salomonsson E, Nilsson UJ, Leffler H.

J Biol Chem. 2012 Jun 22;287(26):21751-6. doi: 10.1074/jbc.C112.358002. Epub 2012 May 1.

31.

Galectin-3 endocytosis by carbohydrate independent and dependent pathways in different macrophage like cell types.

Lepur A, Carlsson MC, Novak R, Dumić J, Nilsson UJ, Leffler H.

Biochim Biophys Acta. 2012 Jul;1820(7):804-18. doi: 10.1016/j.bbagen.2012.02.018. Epub 2012 Mar 17.

PMID:
22450157
32.

Different fractions of human serum glycoproteins bind galectin-1 or galectin-8, and their ratio may provide a refined biomarker for pathophysiological conditions in cancer and inflammatory disease.

Carlsson MC, Balog CI, Kilsgård O, Hellmark T, Bakoush O, Segelmark M, Fernö M, Olsson H, Malmström J, Wuhrer M, Leffler H.

Biochim Biophys Acta. 2012 Sep;1820(9):1366-72. doi: 10.1016/j.bbagen.2012.01.007. Epub 2012 Jan 17.

PMID:
22285770
33.

Glycoproteomic identification of galectin-3 and -8 ligands in bronchoalveolar lavage of mild asthmatics and healthy subjects.

Cederfur C, Malmström J, Nihlberg K, Block M, Breimer ME, Bjermer L, Westergren-Thorsson G, Leffler H.

Biochim Biophys Acta. 2012 Sep;1820(9):1429-36. doi: 10.1016/j.bbagen.2011.12.016. Epub 2012 Jan 4.

PMID:
22240167
34.

Galectin-3 deficiency prevents concanavalin A-induced hepatitis in mice.

Volarevic V, Milovanovic M, Ljujic B, Pejnovic N, Arsenijevic N, Nilsson U, Leffler H, Lukic ML.

Hepatology. 2012 Jun;55(6):1954-64. doi: 10.1002/hep.25542. Epub 2012 Apr 25.

PMID:
22213244
35.

Galectin-8 in IgA nephritis: decreased binding of IgA by galectin-8 affinity chromatography and associated increased binding in non-IgA serum glycoproteins.

Carlsson MC, Bakoush O, Tengroth L, Kilsgård O, Malmström J, Hellmark T, Segelmark M, Leffler H.

J Clin Immunol. 2012 Apr;32(2):246-55. doi: 10.1007/s10875-011-9618-3. Epub 2011 Dec 16.

36.

Taloside inhibitors of galectin-1 and galectin-3.

Collins PM, Oberg CT, Leffler H, Nilsson UJ, Blanchard H.

Chem Biol Drug Des. 2012 Mar;79(3):339-46. doi: 10.1111/j.1747-0285.2011.01283.x. Epub 2012 Jan 11.

PMID:
22136701
37.

The carbohydrate-binding site in galectin-3 is preorganized to recognize a sugarlike framework of oxygens: ultra-high-resolution structures and water dynamics.

Saraboji K, Håkansson M, Genheden S, Diehl C, Qvist J, Weininger U, Nilsson UJ, Leffler H, Ryde U, Akke M, Logan DT.

Biochemistry. 2012 Jan 10;51(1):296-306. doi: 10.1021/bi201459p. Epub 2011 Dec 7.

38.

Regulation of transforming growth factor-β1-driven lung fibrosis by galectin-3.

Mackinnon AC, Gibbons MA, Farnworth SL, Leffler H, Nilsson UJ, Delaine T, Simpson AJ, Forbes SJ, Hirani N, Gauldie J, Sethi T.

Am J Respir Crit Care Med. 2012 Mar 1;185(5):537-46. doi: 10.1164/rccm.201106-0965OC. Epub 2011 Nov 17.

39.

Inhibition mechanism of human galectin-7 by a novel galactose-benzylphosphate inhibitor.

Masuyer G, Jabeen T, Öberg CT, Leffler H, Nilsson UJ, Acharya KR.

FEBS J. 2012 Jan;279(2):193-202. doi: 10.1111/j.1742-4658.2011.08414.x. Epub 2011 Nov 30.

40.

Galectin-1-binding glycoforms of haptoglobin with altered intracellular trafficking, and increase in metastatic breast cancer patients.

Carlsson MC, Cederfur C, Schaar V, Balog CI, Lepur A, Touret F, Salomonsson E, Deelder AM, Fernö M, Olsson H, Wuhrer M, Leffler H.

PLoS One. 2011;6(10):e26560. doi: 10.1371/journal.pone.0026560. Epub 2011 Oct 18.

41.

Arene-anion based arginine-binding motif on a galactose scaffold: structure-activity relationships of interactions with arginine-rich galectins.

Öberg CT, Noresson AL, Leffler H, Nilsson UJ.

Chemistry. 2011 Jul 11;17(29):8139-44. doi: 10.1002/chem.201003247. Epub 2011 Jun 7.

PMID:
21656580
42.

Inhibition of galectins with small molecules.

Oberg CT, Leffler H, Nilsson UJ.

Chimia (Aarau). 2011;65(1-2):18-23. Review.

PMID:
21469439
43.

The anti-angiogenic peptide anginex greatly enhances galectin-1 binding affinity for glycoproteins.

Salomonsson E, Thijssen VL, Griffioen AW, Nilsson UJ, Leffler H.

J Biol Chem. 2011 Apr 22;286(16):13801-4. doi: 10.1074/jbc.C111.229096. Epub 2011 Mar 3.

44.

Protein flexibility and conformational entropy in ligand design targeting the carbohydrate recognition domain of galectin-3.

Diehl C, Engström O, Delaine T, Håkansson M, Genheden S, Modig K, Leffler H, Ryde U, Nilsson UJ, Akke M.

J Am Chem Soc. 2010 Oct 20;132(41):14577-89. doi: 10.1021/ja105852y.

45.

Monovalent interactions of galectin-1.

Salomonsson E, Larumbe A, Tejler J, Tullberg E, Rydberg H, Sundin A, Khabut A, Frejd T, Lobsanov YD, Rini JM, Nilsson UJ, Leffler H.

Biochemistry. 2010 Nov 9;49(44):9518-32. doi: 10.1021/bi1009584.

PMID:
20873803
46.

Galectin inhibitory disaccharides promote tumour immunity in a breast cancer model.

Stannard KA, Collins PM, Ito K, Sullivan EM, Scott SA, Gabutero E, Darren Grice I, Low P, Nilsson UJ, Leffler H, Blanchard H, Ralph SJ.

Cancer Lett. 2010 Dec 28;299(2):95-110. doi: 10.1016/j.canlet.2010.08.005. Epub 2010 Sep 9.

PMID:
20826047
47.

Mutational tuning of galectin-3 specificity and biological function.

Salomonsson E, Carlsson MC, Osla V, Hendus-Altenburger R, Kahl-Knutson B, Oberg CT, Sundin A, Nilsson R, Nordberg-Karlsson E, Nilsson UJ, Karlsson A, Rini JM, Leffler H.

J Biol Chem. 2010 Nov 5;285(45):35079-91. doi: 10.1074/jbc.M109.098160. Epub 2010 Aug 31.

48.

Multimeric lactoside "click clusters" as tools to investigate the effect of linker length in specific interactions with peanut lectin, galectin-1, and -3.

Gouin SG, García Fernández JM, Vanquelef E, Dupradeau FY, Salomonsson E, Leffler H, Ortega-Muñoz M, Nilsson UJ, Kovensky J.

Chembiochem. 2010 Jul 5;11(10):1430-42. doi: 10.1002/cbic.201000167.

PMID:
20549756
49.

1H-1,2,3-triazol-1-yl thiodigalactoside derivatives as high affinity galectin-3 inhibitors.

Salameh BA, Cumpstey I, Sundin A, Leffler H, Nilsson UJ.

Bioorg Med Chem. 2010 Jul 15;18(14):5367-78. doi: 10.1016/j.bmc.2010.05.040. Epub 2010 May 20.

PMID:
20538469
50.

Galectin-3, a marker for vacuole lysis by invasive pathogens.

Paz I, Sachse M, Dupont N, Mounier J, Cederfur C, Enninga J, Leffler H, Poirier F, Prevost MC, Lafont F, Sansonetti P.

Cell Microbiol. 2010 Apr 1;12(4):530-44. doi: 10.1111/j.1462-5822.2009.01415.x. Epub 2009 Nov 27.

PMID:
19951367

Supplemental Content

Loading ...
Support Center